N/A
N=46
Measuring and Improving the Safety of Test Result Follow-Up
Lung Cancer · Breast Cancer · Colon Cancer · Bladder Cancer · Hepatocellular Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04166240 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Trigger Outcome — 67.0; 65.9; 78.6; 78.1 percentage of abnormal tests w/ followup
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- SAFER TRACKS Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Trigger Outcome |
67.0; 65.9; 78.6; 78.1; 67.7; 78.2 | — |
| PRIMARY External Peer Review Program (EPRP) Outcome |
— | — |
Summary
Improving communication is foundational to improving patient safety. Electronic health records (EHRs) can improve communication, but also introduce unique vulnerabilities. Failure to follow-up abnormal test results (missed results) is a key preventable factor in diagnosis and treatment delays in the Veteran's Health Administration (VHA) and often involves EHR-based communication breakdowns. Effective methods are needed to detect diagnostic delays and intervene appropriately. Manual techniques to detect care delays, such as spontaneous reporting and random chart reviews, have limited effectiveness, due in part to bias and lack of provider awareness of delays. They are also inefficient and cost-prohibitive when applied to large numbers of patients.
Diagnostic errors are considered harder to tackle, in part because they are difficult to measure. Rigorous measurement of diagnostic safety is essential and should be prioritized given the increasing amount of electronically available data. To create an effective measurement and learning program researchers must (1) ensure teams know how to take actionable steps on data and have assistance in doing so and (2) prioritize diagnostic safety at the organizational level by securing commitment from local VA leadership and clinical operations personnel. This will ensure that safety measurement will translate into action. The proposed study focuses on creating a novel program to develop and evaluate multifaceted socio-technical tools and strategies to help prevent, detect, mitigate, and ameliorate breakdowns in EHR-based communication that often lead to "missed" test results in the VHA.
Eligibility Criteria
Inclusion Criteria
- Medical records identified via CDW which fall under the EPRP measures (Fecal Occult Blood Test FOBT)/Fecal Immunohistochemical Test (FIT), Hepatitis C Virus (HCV), Mammogram, alpha feto protein (AFP), dual energy x-ray absorptiometry (DEXA) Scan, Pap/ human papillomavirus (HPV), Chest X-ray, and Chest CT)
- Medical records containing clinical findings suspicious for breast cancer, lung cancer, bladder cancer, hepatocellular carcinoma, and colorectal cancer (CRC)
Exclusion Criteria
- Medical records that don't contain any tests, procedures, or appointments that need to be followed up on
Data sourced from ClinicalTrials.gov (NCT04166240). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.